ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

Postepy w Kardiologii Interwencyjnej is a prominent scholarly journal dedicated to the field of interventional cardiology, published by the esteemed TERMEDIA PUBLISHING HOUSE LTD. Since its transition to an Open Access model in 2005, this journal has provided a platform for the dissemination of valuable research and clinical insights, reaching a broad audience of researchers, healthcare professionals, and students in Poland and beyond. With an ISSN of 1734-9338 and E-ISSN of 1897-4295, the journal has established its relevance by featuring articles that are currently indexed in Scopus, reflecting its impact in the field, particularly with a rank of #269 out of 387 in the category of Cardiology and Cardiovascular Medicine for 2023. The publication has continuously evolved to meet the demands of the scientific community, making it an essential resource for staying informed about the latest advancements in interventional techniques and cardiology research. With its commitment to enhancing the knowledge base of cardiovascular medicine, Postepy w Kardiologii Interwencyjnej plays a critical role in fostering collaboration and innovation within this vital specialty.

Kardiologia Polska, the esteemed journal of the Polish Cardiac Society, has established itself as a vital resource in the field of cardiology and cardiovascular medicine since its inception in 1954. With an ISSN of 0022-9032 and an E-ISSN of 1897-4279, this journal serves as a platform for groundbreaking research and scholarly articles that contribute to the advancement of heart health. Although currently not an open access journal, it remains an essential reference for practitioners and researchers seeking to stay abreast of the latest developments in cardiovascular science. The journal reflects its scholarly depth through a Category Quartile of Q3 and a commendable Scopus ranking at the 48th percentile in its field. Published primarily in Poland, it caters to a global audience eager to explore comprehensive studies spanning clinical cardiology, innovative therapeutic approaches, and emerging cardiovascular trends. Join a thriving academic community by engaging with the invaluable insights and research contributions found within the pages of Kardiologia Polska.

EuroIntervention is a prestigious academic journal dedicated to the field of cardiology and cardiovascular medicine, published by EUROPA EDITION. Established as an essential resource for researchers and healthcare professionals, the journal holds an impressive Q1 ranking in both Cardiology and Cardiovascular Medicine as of 2023, demonstrating its influence and commitment to advancing knowledge in these fields. With an ISSN of 1774-024X and an E-ISSN of 1969-6213, EuroIntervention aims to publish high-quality research and clinical studies that address contemporary challenges in cardiovascular therapies. The journal is recognized for its rigorous peer-review process, ensuring that each article contributes valuable insights to the community. Researchers will find EuroIntervention a vital platform to disseminate their findings and engage with innovative cardiology techniques. Operating from France, the journal aspires to bridge the gap between research and clinical practice, making it an essential read for cardiologists, medical professionals, and students alike, keen to stay abreast of the latest advancements in cardiovascular care.

CARDIOVASCULAR DRUGS AND THERAPY, published by Springer, is a premier journal dedicated to the latest advances in cardiovascular pharmacology and therapeutics. With a significant impact factor and esteemed rankings in cardiology and pharmacology, this journal is positioned in the top quartile categories, reflecting its influence and contribution to the field. Since its inception in 1987, the journal has served an international audience, providing a platform for researchers and practitioners to publish high-quality original research, critical reviews, and innovative clinical studies that address pressing issues in cardiovascular health. The journal's rigorous peer-review process ensures the utmost scholarly merit, making it an essential resource for professionals aiming to stay at the forefront of cardiovascular drug research and therapy. While not an open-access publication, it is widely available through institutional subscriptions, enhancing its reach within the global community of cardiology researchers and practitioners. Located in the Netherlands, CARDIOVASCULAR DRUGS AND THERAPY continues to play a vital role in advancing our understanding of cardiovascular diseases and the pharmacological solutions available to combat them.

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.